| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.3M | +40.8% |
| Cost of Revenue | $872K | +60.1% |
| R&D Expense | $7.6M | -7.8% |
| SG&A Expense | $6.6M | +5.1% |
| Operating Income | -$17.6M | +1.1% |
| Pre-tax Income | -$18.6M | +1.0% |
| Income Tax | $1K | -86.5% |
| Net Income | -$18.6M | +1.0% |
| EPS (Basic) | -$0.47 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $9.3M | +168.5% |
| Accounts Receivable | $617K | +26.3% |
| Inventory | $5.7M | +88.4% |
| Current Assets | $16.5M | +105.1% |
| Total Assets | $20.7M | +66.5% |
| Current Liabilities | $3.6M | -57.6% |
| Total Liabilities | $14.9M | +46.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$18.7M | +3.9% |
| Capital Expenditures | $525K | -31.1% |
| Investing Cash Flow | -$630K | +25.7% |
| Financing Cash Flow | $25.1M | +1139.7% |
| Free Cash Flow | -$19.2M | +4.9% |
| +44.7% |
| EPS (Diluted) | -$0.47 | +44.7% |
| Stockholders' Equity |
| $5.9M |
| +154.7% |